Seroepidemiological surveillance of antitetanus antibodies in Pakistani childbearing women: A population based survey

Maternal and Neonatal Tetanus is a severe, often fatal ailment characterized by sweeping augmented strictness and convulsive spasms of skeletal muscles. Vaccination is the most steadfast method of forbearance against this disease and has inculcated to lessen mortalities. The present study was carried out with a view to assess the serum levels of tetanus antitoxins in randomly selected rural and urban women to find out the effect of age, number of pregnancy, parity and number of injections at the time of delivery. The study was cross-sectional in design and hospital-based. The gold standard mouse neutralization assay was employed despite being costly and cumbersome. Antibody titre of each sample was determined by seroneutralization method. 1504 women, randomly selected from various hospitals of age 15 to 40 years, 1064 (0.000) were vaccinated, which are significant while 440 were unvaccinated women and taken as control. The 65% (p = 0.000) women had antibody titre higher than protective level which is significant, 28% equal to protective level and 6.7% below protective level. Average antibody titre of 3rd trimester was higher than 2nd trimester (p = 0.000) which is significant. Immunization awareness and practice was higher in 30 years in women (63%) of both rural and urban areas but practice was comparatively higher in urban (74%) than rural area (67%). These finding shows that tetanus vaccination in our population is generally effective and cannot be protected by herd immunity, as tetanus is not communicable disease. Key words: Antitetanus antibodies, seroneutralization, childbearing age, Pakistan. INTRODUCTION Tetanus caused by Clostridium tetani , is a vaccine-preventable, global infectious disease with significant morbidity and mortality. The global status of serological immunity against tetanus varies between countries as a result of different national vaccination policies and methods, and the criteria used for determination of serum levels of tetanus antitoxin. Protective immunity was noted

[1]  F. Gasse,et al.  Maternal and neonatal tetanus , 2007, The Lancet.

[2]  P. Chatchatee,et al.  Seroprevalence of tetanus antibody in the Thai population: a national survey. , 2007, Asian Pacific journal of allergy and immunology.

[3]  K. Miyamura,et al.  Tetanus immunization status among women of childbearing age in Turkey. , 2007, Japanese journal of infectious diseases.

[4]  I. Jehan,et al.  Knowledge, attitude and practices of reproductive age females about tetanus toxoid vaccine: a pilot study. , 2006, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[5]  S. Erdoğan,et al.  Prevalence of tetanus immunity in the Kocaeli Region, Turkey. , 2005, Japanese journal of infectious diseases.

[6]  M. Burgess,et al.  Immunity to diphtheria and tetanus in Australia: a national serosurvey , 2005, The Medical journal of Australia.

[7]  J. Hatcher,et al.  Coverage and factors associated with tetanus toxoid vaccination status among females of reproductive age in Peshawar. , 2005, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[8]  A. Thind Determinants of tetanus toxoid immunization in pregnancy in rural Bihar , 2005, Tropical doctor.

[9]  A. Tamer,et al.  Tetanus immunity in nursing home residents of Bolu, Turkey , 2005, BMC public health.

[10]  U. Griffiths,et al.  Incremental cost-effectiveness of supplementary immunization activities to prevent neonatal tetanus in Pakistan. , 2004, Bulletin of the World Health Organization.

[11]  F. Gasse,et al.  Tetanus in developing countries: an update on the Maternal and Neonatal Tetanus Elimination Initiative. , 2003, Vaccine.

[12]  A. Dharmalingam,et al.  Utilization of maternal health care services in Southern India. , 2002, Social science & medicine.

[13]  Z. Baykan,et al.  Tetanus immunization in pregnant women: evaluation of maternal tetanus vaccination status and factors affecting rate of vaccination coverage. , 2001, Public health.

[14]  W. Edmunds,et al.  Immunity to diphtheria and tetanus in England and Wales. , 2000, Vaccine.

[15]  P. Gergen,et al.  A Population-Based Serologic Survey of Immunity to Tetanus in the United States , 1995 .

[16]  F. Black,et al.  Tetanus antitoxin titers in women of childbearing age from nine diverse populations. , 1985, The Journal of infectious diseases.

[17]  K. Kjeldsen,et al.  IMMUNITY AGAINST TETANUS AND EFFECT OF REVACCINATION 25-30 YEARS AFTER PRIMARY VACCINATION , 1984, The Lancet.

[18]  V. Rao,et al.  Antibody response to tetanus toxoid during pregnancy. , 1980, The Indian journal of medical research.

[19]  F. Erdem,et al.  Tetanus antitoxin levels among adults over 40 years of age in Central Anatolia, Turkey. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  M. Deming,et al.  Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus. , 2002, Bulletin of the World Health Organization.

[21]  H. Perry,et al.  Tetanus toxoid immunization coverage among women in zone 3 of Dhaka city: the challenge of reaching all women of reproductive age in urban Bangladesh. , 1998, Bulletin of the World Health Organization.

[22]  K. Kjeldsen,et al.  Immunity against diphtheria and tetanus in the age group 30-70 years. , 1988, Scandinavian journal of infectious diseases.

[23]  B. Christenson,et al.  Epidemiology and immunity to tetanus in Sweden. , 1987, Scandinavian journal of infectious diseases.

[24]  O. Simonsen,et al.  ELISA for the routine determination of antitoxic immunity to tetanus. , 1986, Journal of biological standardization.

[25]  C. Pini,et al.  The use of an immunoenzymatic assay for the estimation of tetanus antitoxin in human sera: a comparison with seroneutralization and indirect haemagglutination. , 1985, Journal of biological standardization.

[26]  C. J. Maloney,et al.  Immunization against neonatal tetanus in New Guinea. , 1970, Bulletin of the World Health Organization.